NASDAQ: ARTL
Artelo Biosciences Inc Stock Ownership - Who owns Artelo Biosciences?

Insider buying vs selling

Have Artelo Biosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ARTL insiders and whales buy or sell their stock.

ARTL Shareholders

What type of owners hold Artelo Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter Michael Obrien14.78%345,000$351.90kInsider
Gregory D. Gorgas11.70%273,076$278.54kInsider
John Joseph Crawford4.10%95,671$97.58kInsider
Sharon M. Oster2.67%62,373$63.62kInsider
Connie Matsui2.43%56,667$57.80kInsider
Kathmere Capital Management LLC0.57%13,250$13.52kInstitution
Jane Street Group LLC0.56%13,079$13.34kInstitution
Vanguard Capital Management LLC0.43%10,129$10.33kInstitution
Vanguard Fiduciary Trust Co0.13%3,139$3.20kInstitution
Citigroup Inc0.13%3,076$3.14kInstitution

1 of 3

ARTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTL1.99%35.73%
OGEN0.48%99.52%Net Selling
GRI1.02%98.98%
MTNB1.16%98.84%
CLDI10.40%82.03%Net Buying

Artelo Biosciences Stock Ownership FAQ

Who owns Artelo Biosciences?

Artelo Biosciences (NASDAQ: ARTL) is owned by 1.99% institutional shareholders, 35.73% Artelo Biosciences insiders, and 62.28% retail investors. Peter Michael Obrien is the largest individual Artelo Biosciences shareholder, owning 345,000.00 shares representing 14.78% of the company. Peter Michael Obrien's Artelo Biosciences shares are currently valued at $348.45k.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.